Isabelle Gourlaouen

469 total citations
17 papers, 231 citations indexed

About

Isabelle Gourlaouen is a scholar working on Hematology, Genetics and Nutrition and Dietetics. According to data from OpenAlex, Isabelle Gourlaouen has authored 17 papers receiving a total of 231 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 13 papers in Genetics and 9 papers in Nutrition and Dietetics. Recurrent topics in Isabelle Gourlaouen's work include Iron Metabolism and Disorders (15 papers), Hemoglobinopathies and Related Disorders (13 papers) and Trace Elements in Health (9 papers). Isabelle Gourlaouen is often cited by papers focused on Iron Metabolism and Disorders (15 papers), Hemoglobinopathies and Related Disorders (13 papers) and Trace Elements in Health (9 papers). Isabelle Gourlaouen collaborates with scholars based in France, Guadeloupe and Italy. Isabelle Gourlaouen's co-authors include Gérald Le Gac, Claude Férec, Chandran Ka, Isabelle Callebaut, Pierre Lehn, Jean‐Paul Mornon, Paola Grammatico, Carmelilia De Bernardo, Francesca Clementina Radio and Silvia Majore and has published in prestigious journals such as Blood, PLoS ONE and The FASEB Journal.

In The Last Decade

Isabelle Gourlaouen

16 papers receiving 228 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Isabelle Gourlaouen France 8 196 164 153 37 21 17 231
Chandran Ka France 9 185 0.9× 146 0.9× 121 0.8× 50 1.4× 21 1.0× 20 246
Iwan Buetti Italy 3 80 0.4× 72 0.4× 27 0.2× 12 0.3× 3 0.1× 7 122
Outi Kämäräinen United Kingdom 4 49 0.3× 44 0.3× 36 0.2× 62 1.7× 3 0.1× 6 133
Ina Hollerer Germany 8 44 0.2× 36 0.2× 31 0.2× 214 5.8× 9 0.4× 10 273
Marta Polo Spain 7 87 0.4× 79 0.5× 7 0.0× 11 0.3× 4 0.2× 18 115
Szu Shen Wong United Kingdom 5 35 0.2× 65 0.4× 12 0.1× 37 1.0× 5 0.2× 6 108
Marcin Stobiecki Poland 6 22 0.1× 67 0.4× 20 0.1× 22 0.6× 2 0.1× 22 114
Matthew J. Ferber United States 6 29 0.1× 4 0.0× 75 0.5× 54 1.5× 19 0.9× 6 175
Harold K. K. Lee China 6 117 0.6× 24 0.1× 6 0.0× 134 3.6× 2 0.1× 10 182
Kristina Alikhanyan Germany 4 21 0.1× 15 0.1× 12 0.1× 15 0.4× 3 0.1× 6 49

Countries citing papers authored by Isabelle Gourlaouen

Since Specialization
Citations

This map shows the geographic impact of Isabelle Gourlaouen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Gourlaouen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Gourlaouen more than expected).

Fields of papers citing papers by Isabelle Gourlaouen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabelle Gourlaouen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Gourlaouen. The network helps show where Isabelle Gourlaouen may publish in the future.

Co-authorship network of co-authors of Isabelle Gourlaouen

This figure shows the co-authorship network connecting the top 25 collaborators of Isabelle Gourlaouen. A scholar is included among the top collaborators of Isabelle Gourlaouen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabelle Gourlaouen. Isabelle Gourlaouen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ged, Cécile, Kévin Uguen, Isabelle Gourlaouen, et al.. (2025). Identification of New Key Players for Ferrous Iron Export in the Asymmetric Inner Gate of Human Ferroportin 1. The FASEB Journal. 39(14). e70821–e70821.
2.
Uguen, Kévin, Dimitri Tchernitchko, Isabelle Gourlaouen, et al.. (2024). The dual loss and gain of function of the FPN1 iron exporter results in the ferroportin disease phenotype. Human Genetics and Genomics Advances. 5(4). 100335–100335. 2 indexed citations
3.
Gac, Gérald Le, Virginie Scotet, Isabelle Gourlaouen, et al.. (2022). Prevalence of HFE‐related haemochromatosis and secondary causes of hyperferritinaemia and their association with iron overload in 1059 French patients treated by venesection. Alimentary Pharmacology & Therapeutics. 55(8). 1016–1027. 5 indexed citations
4.
Ka, Chandran, Isabelle Gourlaouen, Gaëlle Richard, et al.. (2020). Splicing analysis of SLC40A1 missense variations and contribution to hemochromatosis type 4 phenotypes. Blood Cells Molecules and Diseases. 87. 102527–102527. 5 indexed citations
5.
Rodríguez‐Palmero, Agustí, Agatha Schlüter, Edgard Verdura, et al.. (2020). A novel hypomorphic splice variant in EIF2B5 gene is associated with mild ovarioleukodystrophy. Annals of Clinical and Translational Neurology. 7(9). 1574–1579. 4 indexed citations
6.
Ka, Chandran, Isabelle Gourlaouen, Isabelle Callebaut, et al.. (2019). Functional analysis of novel RHD variants: splicing disruption is likely to be a common mechanism of variant D phenotype. Transfusion. 59(4). 1367–1375. 14 indexed citations
7.
Uguen, Kévin, Isabelle Gourlaouen, Claude Férec, et al.. (2019). Molecular model of the ferroportin intracellular gate and implications for the human iron transport cycle and hemochromatosis type 4A. The FASEB Journal. 33(12). 14625–14635. 14 indexed citations
8.
Ka, Chandran, Caroline Kannengiesser, Cécile Ged, et al.. (2018). The SLC40A1 R178Q mutation is a recurrent cause of hemochromatosis and is associated with a novel pathogenic mechanism. Haematologica. 103(11). 1796–1805. 20 indexed citations
10.
Callebaut, Isabelle, Serge Pissard, Caroline Kannengiesser, et al.. (2014). Comprehensive functional annotation of 18 missense mutations found in suspected hemochromatosis type 4 patients. Human Molecular Genetics. 23(17). 4479–4490. 35 indexed citations
11.
Saliou, Philippe, Gérald Le Gac, Paul Guéguen, et al.. (2013). Evidence for the High Importance of Co-Morbid Factors in HFE C282Y/H63D Patients Cared by Phlebotomies: Results from an Observational Prospective Study. PLoS ONE. 8(12). e81128–e81128. 5 indexed citations
12.
Cézard, Christine, et al.. (2013). Phenotypic expression of a novel C282Y/R226G compound heterozygous state in HFE hemochromatosis: Molecular dynamics and biochemical studies. Blood Cells Molecules and Diseases. 52(1). 27–34. 7 indexed citations
13.
Gac, Gérald Le, Chandran Ka, Isabelle Gourlaouen, et al.. (2013). Structure-Function Analysis of the Human Ferroportin Iron Exporter (SLC40A1): Effect of Hemochromatosis Type 4 Disease Mutations and Identification of Critical Residues. Human Mutation. 34(10). 1371–1380. 47 indexed citations
14.
Gac, Gérald Le, Silvia Majore, Chandran Ka, et al.. (2009). A novel missense mutation in SLC40A1 results in resistance to hepcidin and confirms the existence of two ferroportin‐associated iron overload diseases. British Journal of Haematology. 147(3). 379–385. 32 indexed citations
15.
Milet, Jacqueline, Gérald Le Gac, Virginie Scotet, et al.. (2009). A common SNP near BMP2 is associated with severity of the iron burden in HFE p.C282Y homozygous patients: A follow-up study. Blood Cells Molecules and Diseases. 44(1). 34–37. 25 indexed citations
17.
Gac, Gérald Le, Isabelle Gourlaouen, Christophe Ronsin, et al.. (2008). Homozygous deletion of HFE produces a phenotype similar to the HFE p.C282Y/p.C282Y genotype. Blood. 112(13). 5238–5240. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026